A systematic review of microvascular invasion in hepatocellular carcinoma: diagnostic and prognostic variability
M Rodriguez-Peralvarez, TV Luong… - Annals of surgical …, 2013 - Springer
Selected patients with hepatocellular carcinoma are candidates to receive potentially
curative treatments, such as hepatic resection or liver transplantation, but nevertheless there …
curative treatments, such as hepatic resection or liver transplantation, but nevertheless there …
[HTML][HTML] Hepatocellular carcinoma review: current treatment, and evidence-based medicine
A Raza, GK Sood - World journal of gastroenterology: WJG, 2014 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is the fifth most common tumor worldwide. Multiple
treatment options are available for HCC including curative resection, liver transplantation …
treatment options are available for HCC including curative resection, liver transplantation …
[HTML][HTML] Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection
Background & Aims Resection is the most widely used potentially curative treatment for
patients with early hepatocellular carcinoma (HCC). However, recurrence within 2 years …
patients with early hepatocellular carcinoma (HCC). However, recurrence within 2 years …
Risk factors, patterns, and outcomes of late recurrence after liver resection for hepatocellular carcinoma: a multicenter study from China
XF Xu, H Xing, J Han, ZL Li, WY Lau, YH Zhou… - JAMA …, 2019 - jamanetwork.com
Importance Late recurrence (more than 2 years) after liver resection for hepatocellular
carcinoma (HCC) is generally considered as a multicentric tumor or a de novo cancer …
carcinoma (HCC) is generally considered as a multicentric tumor or a de novo cancer …
Preoperative gadoxetic acid–enhanced MRI for predicting microvascular invasion in patients with single hepatocellular carcinoma
Background & Aims This study aimed to identify preoperative magnetic resonance (MR)
imaging biomarkers for predicting microvascular invasion (MVI), to determine their …
imaging biomarkers for predicting microvascular invasion (MVI), to determine their …
EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma
European Association For The Study Of … - Journal of …, 2012 - journal-of-hepatology.eu
EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …
[HTML][HTML] EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma
EO for Research… - Journal of …, 2012 - Elsevier
EASL–EORTC Clinical Practice Guidelines (CPG) on the management of hepatocellular
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …
carcinoma (HCC) define the use of surveillance, diagnosis, and therapeutic strategies …
Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent
Background The objective of this study was to investigate the characteristics, treatment and
prognosis of early versus late recurrence of intrahepatic cholangiocarcinoma (ICC) after …
prognosis of early versus late recurrence of intrahepatic cholangiocarcinoma (ICC) after …
[PDF][PDF] Loco‐regional treatment of hepatocellular carcinoma
R Lencioni - Hepatology, 2010 - Wiley Online Library
Loco‐regional treatments play a key role in the management of hepatocellular carcinoma
(HCC). Image‐guided tumor ablation is recommended in patients with early‐stage HCC …
(HCC). Image‐guided tumor ablation is recommended in patients with early‐stage HCC …
Local-regional treatment of hepatocellular carcinoma
R Lencioni, L Crocetti - Radiology, 2012 - pubs.rsna.org
Local-regional treatments play a key role in the management of hepatocellular carcinoma
(HCC). Image-guided tumor ablation is recommended in patients with early-stage HCC …
(HCC). Image-guided tumor ablation is recommended in patients with early-stage HCC …